Att A - Offeror Capabilities and Specimens.xlsx
XLSX spreadsheet 27 KB Posted
- Solicitation number
- 75D301-22-R-72117
About this file
This document contains a pre-solicitation synopsis and proposal template for laboratory testing services. The Centers for Disease Control and Prevention intends to competitively award firm fixed-price contracts valued at approximately eleven months with an optional twelve month extension. The purpose is to determine U.S. SARS-CoV-2 seroprevalence by region, age, and time through testing of de-identified residual blood specimens provided by offerors. Technical evaluation factors will be more important than price. Multiple awards are anticipated to achieve coverage of all 50 states, Washington D.C., and Puerto Rico. The solicitation is expected to publish within 7-15 days with proposals due 20-30 days after release. Offerors should regularly monitor the website for any amendments. The template requests information on testing capabilities, available specimen quantities and locations from offerors.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Att B - Task Deliverables Table.xlsx | XLSX spreadsheet | |
| Draft Performance Work Statement - Mass Serology.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Proposal Responses
| Each offeror should complete and include the below table and subsequent worksheets with their proposal. | ||
| ID | Question | Answer |
| A.1 | How many total specimens from each US state (+ DC and Puerto Rico), stratified by age group, do you typically accumulate over a one week period that could be used in this study? | |
| A.2 | Provide aggregated, available information on the specimens referenced in Question 1 in the below worksheet tab labeled "A.3". | |
| B.1 | How many total specimens from each US state (+ DC and Puerto Rico), stratfied by age group, do you typically accumulate overan eight week period that could be used in this study? | |
| B.2 | Provide aggregated, available information on the specimens referenced in Question 1 in the below worksheet tab labeled "B.3". | |
| C | Please describe if and how you can monitor and adjust for geographic representativeness of specimens selected for testing within a jurisdiction | |
| D.1 | Will you provide sample results and metadata information as both Excel and .CSV file types? | |
| D.2 | Which of the requested variables do you anticipate limitations in your availability to provide in at least 50% of results submitted [Race and ethnicity; 5-digit zip code of patient residence (provider zip code if not available); name of the original laboratory test (e.g. basic metabolic panel, lipid panel);ICD10 diagnosis associated with the original laboratory test; Results (including collection date) of any previous COVID-19 testing on the same patient, including previous PCR testing for SARS-CoV-2 infection or previous testing for SARS-CoV-2 antibodies (antibody assay type should be included, if available); Information on if the specimen came from an outpatient or inpatient facility; Information on payer by category (e.g., private insurer/HMO, Medicaid, Medicare, self-pay, military health system); Unique patient identifier to allow for deduplication of sample results from the same patient in the same round] | |
| E | Do you have any relevant partnerships with organizations serving pediatric populations or other ideas for how to optimize the number of pediatric specimens for testing? | |
| F | How many specimens can you test under Task Area 1 every 8 weeks? | |
| G | How many specimens can you test under Task Area 2 every 8 weeks? | |
| H | Please addend a table of how many lab locations or specimen collection sites you have in each jurisdiction you are applying to cover, by county. Offeror(s) may use the format most convenient to them to convey this information. |
A.3
| With reference to Questions A.1 in "Proposal Responses", provide any of the below information readily available: | ||||
| Jurisdiction (50 states, DC, Puerto Rico) | Estimated # of available specimens (per typical week) | |||
| People aged 0-11 yrs | People aged 12-17 yrs | |||
| Existing labs | Via subcontract | Existing labs | Via subcontract |
B.3
| With reference to Questions B.1 in "Proposal Responses", provide any of the below information readily available: | ||||
| Jurisdiction (50 states, DC, Puerto Rico) | Estimated # of available specimens (per 8 weeks) | |||
| People aged 0-11 yrs | People aged 12-17 yrs | |||
| Existing labs | Via subcontract | Existing labs | Via subcontract |
File details come from the government source that posted it. Updated .